- 全部删除
- 您的购物车当前为空
LM-305是一种靶向GPRC5D的抗体偶联药物(ADC),由GPRC5D人源化单克隆抗体、可降解蛋白酶连接子和细胞毒素MMAE组成,可用于研究多发性骨髓瘤和实体瘤。
为众多的药物研发团队赋能,
让新药发现更简单!
LM-305是一种靶向GPRC5D的抗体偶联药物(ADC),由GPRC5D人源化单克隆抗体、可降解蛋白酶连接子和细胞毒素MMAE组成,可用于研究多发性骨髓瘤和实体瘤。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 1,300 | In stock | |
5 mg | ¥ 3,250 | In stock | |
10 mg | ¥ 4,730 | In stock | |
25 mg | ¥ 7,490 | In stock | |
50 mg | ¥ 9,870 | In stock | |
100 mg | ¥ 13,600 | In stock |
LM-305 相关产品
产品描述 | LM-305 is an antibody-drug conjugate (ADC) targeting GPRC5D, composed of a humanised monoclonal antibody against GPRC5D, a degradable protease linker, and the cytotoxic agent MMAE, and can be used for research on multiple myeloma and solid tumours. |
存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容